184 related articles for article (PubMed ID: 29540879)
21. Longitudinal alveolar bone loss in postmenopausal osteoporotic/osteopenic women.
Payne JB; Reinhardt RA; Nummikoski PV; Patil KD
Osteoporos Int; 1999; 10(1):34-40. PubMed ID: 10501777
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait.
Al-Shoumer KA; Nair V
Arch Osteoporos; 2012; 7():147-53. PubMed ID: 23225292
[TBL] [Abstract][Full Text] [Related]
23. The levels of bone turnover markers in Chinese postmenopausal women: Peking Vertebral Fracture study.
Zhao J; Xia W; Nie M; Zheng X; Wang Q; Wang X; Wang W; Ning Z; Huang W; Jiang Y; Li M; Wang O; Xing X; Sun Y; Luo L; He S; Yu W; Lin Q; Pei Y; Zhang F; Han Y; Tong Y; Che Y; Shen R; Hu Y; Zhou X; Xu L
Menopause; 2011 Nov; 18(11):1237-43. PubMed ID: 21747303
[TBL] [Abstract][Full Text] [Related]
24. Association between polymorphisms in tumor necrosis factor (TNF) and TNF receptor genes and circulating TNF, soluble TNF receptor levels, and bone mineral density in postmenopausal Korean women.
Kim H; Chun S; Ku SY; Suh CS; Choi YM; Kim JG
Menopause; 2009; 16(5):1014-20. PubMed ID: 19369902
[TBL] [Abstract][Full Text] [Related]
25. Changes of serum cytokines-related Th1/Th2/Th17 concentration in patients with postmenopausal osteoporosis.
Zhang J; Fu Q; Ren Z; Wang Y; Wang C; Shen T; Wang G; Wu L
Gynecol Endocrinol; 2015 Mar; 31(3):183-90. PubMed ID: 25384921
[TBL] [Abstract][Full Text] [Related]
26. How does quantitative ultrasound compare to dual X-ray absorptiometry at various skeletal sites in relation to the WHO diagnosis categories?
Jørgensen HL; Warming L; Bjarnason NH; Andersen PB; Hassager C
Clin Physiol; 2001 Jan; 21(1):51-9. PubMed ID: 11168297
[TBL] [Abstract][Full Text] [Related]
27. Vitamin D2 dose required to rapidly increase 25OHD levels in osteoporotic women.
Mastaglia SR; Mautalen CA; Parisi MS; Oliveri B
Eur J Clin Nutr; 2006 May; 60(5):681-7. PubMed ID: 16391587
[TBL] [Abstract][Full Text] [Related]
28. Relationship between bone mineral density, bone turnover markers and homocysteine, folate and vitamin B12 levels in postmenopausal women.
Haliloglu B; Aksungar FB; Ilter E; Peker H; Akin FT; Mutlu N; Ozekici U
Arch Gynecol Obstet; 2010 Apr; 281(4):663-8. PubMed ID: 19946695
[TBL] [Abstract][Full Text] [Related]
29. Influence of the selective oestrogen receptor modulator (raloxifene hydrochloride) on IL-6, TNF-alpha, TGF-beta1 and bone turnover markers in the treatment of postmenopausal osteoporosis.
Ozmen B; Kirmaz C; Aydin K; Kafesciler SO; Guclu F; Hekimsoy Z
Eur Cytokine Netw; 2007 Sep; 18(3):148-53. PubMed ID: 17823083
[TBL] [Abstract][Full Text] [Related]
30. [The effect of group exercise on postmenopausal osteoporosis and osteopenia].
Angin E; Erden Z
Acta Orthop Traumatol Turc; 2009; 43(4):343-50. PubMed ID: 19809232
[TBL] [Abstract][Full Text] [Related]
31. Association of bone mineral density with periodontal status in postmenopausal women.
Singh A; Sharma RK; Siwach RC; Tewari S; Narula SC
J Investig Clin Dent; 2014 Nov; 5(4):275-82. PubMed ID: 23766246
[TBL] [Abstract][Full Text] [Related]
32. Comparison of serum levels of vitamin D and vitamin D-binding protein in normal, osteopenic and osteoporotic postmenopausal women.
Murad R; Mahboob T; Rehman R; Baig R
Pak J Med Sci; 2019; 35(2):543-548. PubMed ID: 31086548
[TBL] [Abstract][Full Text] [Related]
33. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
[TBL] [Abstract][Full Text] [Related]
34. The effect of cholecystectomy on 25-hydroxyvitamin D levels and bone mineral density in postmenopausal women.
Polat HB; Beyazal MS
Arch Osteoporos; 2018 May; 13(1):61. PubMed ID: 29790021
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the Relation Between Omentin-1 and Vitamin D in Postmenopausal Women With or Without Osteoporosis.
Dikker O; Bekpinar S; Ozdemirler G; Uysal M; Vardar M; Atar S; Usta M; Huner B
Exp Clin Endocrinol Diabetes; 2018 May; 126(5):316-320. PubMed ID: 29117613
[TBL] [Abstract][Full Text] [Related]
36. Comparison of serum insulin-like growth factor-1 and growth hormone levels in osteoporotic and non-osteoporotic postmenopausal women.
Celiker R; Arslan S
Rheumatol Int; 2000; 19(6):205-8. PubMed ID: 11063288
[TBL] [Abstract][Full Text] [Related]
37. Association of serum paraoxonase concentration with serum lipid levels and bone mineral density measurements in early postmenopausal women.
Yoldemir T; Yavuz DG
Climacteric; 2015 Jun; 18(3):405-10. PubMed ID: 25333316
[TBL] [Abstract][Full Text] [Related]
38. A calcium-collagen chelate dietary supplement attenuates bone loss in postmenopausal women with osteopenia: a randomized controlled trial.
Elam ML; Johnson SA; Hooshmand S; Feresin RG; Payton ME; Gu J; Arjmandi BH
J Med Food; 2015 Mar; 18(3):324-31. PubMed ID: 25314004
[TBL] [Abstract][Full Text] [Related]
39. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.
Lips P; Duong T; Oleksik A; Black D; Cummings S; Cox D; Nickelsen T
J Clin Endocrinol Metab; 2001 Mar; 86(3):1212-21. PubMed ID: 11238511
[TBL] [Abstract][Full Text] [Related]
40. In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography.
Boutroy S; Bouxsein ML; Munoz F; Delmas PD
J Clin Endocrinol Metab; 2005 Dec; 90(12):6508-15. PubMed ID: 16189253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
